Regulatory Digest: Cannabis Manufacturing Compliance & Rescheduling
Regulatory cannabis manufacturing compliance is evolving with recent rescheduling updates that impact clinical research. These changes aim to standardize pharmaceutical cannabis production. Understanding these regulations is key for advancing cannabis…
Daily Digest: Last 24 Hours: Brain Aging, Driving Safety, and the Global Fight for Patient Access — March 05, 2026
Recent studies on cannabis cognitive aging older adults provide reassuring data about cognitive decline risks. Evidence shows THC blood levels poorly predict driving impairment. Patient access remains a critical issue in the U.S. and U.K. healthcare…
In the Mix: 9 More Cannabis Articles — March 05, 2026
This digest presents cannabis clinical research updates 2026 with 9 articles reviewed and scored below the clinical relevance threshold. Topics include policy, safety, and anxiety research. Each article summary provides insights and source links for…
Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply
Oklahoma medical cannabis regulations face scrutiny as the state considers rolling back its permissive program. Patients relying on medical cannabis should stay informed about potential changes that could disrupt treatment. Regulatory challenges…
Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire
Pharmaceutical-grade cannabis international markets are evolving due to federal policy changes. GMP-certified producers are positioned to scale and export medical cannabis products. This shift may improve product consistency and availability for patients.
The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
Cannabinoid research barriers in the U.S. create challenges for developing evidence-based cannabis medicines. Federal scheduling under the Controlled Substances Act fragments the regulatory environment. This limits patient access to clinically validated…
Use of Medical Marijuana or Hemp Doesn’t Excuse Drug Testing Violations
2026 cannabis federal workplace regulations clarify that medical marijuana or hemp use does not exempt employees from drug testing violations. Patients using medical cannabis may still face employment consequences despite state legalization. Clinicians…
Congressional Debate on Hemp THC Regulation and Farm Bill
The recent farm bill highlights hemp THC regulation challenges amid ongoing federal uncertainty. Hemp-derived THC products remain in a complex legal gray area. Clinicians face difficulties counseling patients due to shifting hemp THC policies.
Substance Use on the Rise Among Gen Z in Their Early 20s | UCL News
Rising substance use in young adults is a significant trend among Gen Z in their early twenties. Clinicians must understand these patterns to screen and identify at-risk populations effectively. Early intervention can help address substance use and…
Ghana to Grow Its Local Therapeutic Cannabis Industry • FRANCE 24 English – YouTube
Ghana therapeutic cannabis industry development marks a significant shift in African drug policy. This growth could improve access to standardized cannabis-based medications. Clinicians should monitor regulatory progress for patient safety and treatment…